Qulipta 30 mg/1
Atogepant · TABLET · AbbVie Inc.
No Recall History
Plain English
Qulipta is a tablet containing atogepant at 30 mg/1, taken oral. Manufactured by AbbVie Inc..
Key Facts
- Brand Name
- Qulipta
- Generic Name
- Atogepant
- NDC Code (Product)
0074-7096- Manufacturer
- AbbVie Inc.
- Strength
- 30 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA215206
- Drug Class
- Calcitonin Gene-related Peptide Receptor Antagonist [EPC]
- Marketing Start
- 09/30/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Qulipta used for?
Qulipta contains Atogepant. It is a tablet taken oral. Consult your doctor for specific uses.
Is Qulipta a controlled substance?
Qulipta is not classified as a controlled substance by the DEA.
What is the generic name for Qulipta?
The generic name for Qulipta is Atogepant. There are no other listed brand versions of Atogepant.
What is the NDC code for Qulipta 30 mg/1?
The NDC (National Drug Code) for Qulipta 30 mg/1 is 0074-7096, listed by AbbVie Inc..
Other Qulipta Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)